相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004
O. O'Toole et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
G. Logroscino et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Predictors of long survival in amyotrophic lateral sclerosis: A population-based study
Stefano Zoccolella et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
E. J. Sorenson et al.
NEUROLOGY (2008)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Phase II/III randomized trial of TCH346 in patients with ALS
R. Miller et al.
NEUROLOGY (2007)
The value of database controls in pilot or futility studies in ALS
A. Czaplinski et al.
NEUROLOGY (2006)
Trends in hospital utilization and outcome for patients with ALS - Analysis of a large US cohort
Richard Dubinsky et al.
NEUROLOGY (2006)
Slower disease progression and prolonged survival in contemporary with amyotrophic patients lateral sclerosis - Is the natural history of amyotrophic lateral sclerosis changing?
Adam Czaplinski et al.
ARCHIVES OF NEUROLOGY (2006)
Trial of celecoxib in amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
ANNALS OF NEUROLOGY (2006)
Pentoxifylline in ALS: A double-blind, randomized, multicenter, placebo-controlled trial
B Levin et al.
NEUROLOGY (2006)
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis
SC Bourke et al.
LANCET NEUROLOGY (2006)
Pentoxifylline in ALS - A double-blind, randomized, multicenter, placebo-controlled trial
V Meininger et al.
NEUROLOGY (2006)
Multidisciplinary ALS care improves quality of life in patients with ALS
JP Van den Berg et al.
NEUROLOGY (2005)
Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period
D Testa et al.
AMYOTROPHIC LATERAL SCLEROSIS (2004)
Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease
RB Forbes et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Functional outcome measures as clinical trial endpoints in ALS
BJ Traynor et al.
NEUROLOGY (2004)
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials
V Meininger et al.
AMYOTROPHIC LATERAL SCLEROSIS (2004)
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000
BJ Traynor et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis
ME Cudkowicz et al.
NEUROLOGY (2003)
A randomized sequential trial of creatine in amyotrophic lateral sclerosis
GJ Groeneveld et al.
ANNALS OF NEUROLOGY (2003)
Prognosis in amyotrophic lateral sclerosis - A population-based study
MA del Aguila et al.
NEUROLOGY (2003)
Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998
EJ Sorenson et al.
NEUROLOGY (2002)
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis
RG Miller et al.
NEUROLOGY (2001)
分享论文
